[1] |
Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei.
Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction
[J]. Journal of International Oncology, 2024, 51(4): 193-197.
|
[2] |
Gong Yan, Chen Honglei.
Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer
[J]. Journal of International Oncology, 2024, 51(3): 186-190.
|
[3] |
Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.
lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway
[J]. Journal of International Oncology, 2023, 50(4): 202-207.
|
[4] |
Zhao Jianhao, Duan Yanchao.
Research progress in the pathogenesis of extramedullary disease in multiple myeloma
[J]. Journal of International Oncology, 2023, 50(1): 55-59.
|
[5] |
Xiao Nan, Sun Pengfei.
Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas
[J]. Journal of International Oncology, 2022, 49(6): 357-361.
|
[6] |
Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.
MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2
[J]. Journal of International Oncology, 2022, 49(4): 193-198.
|
[7] |
Zhu Yishuo, Cui Yujie, Liu Qi, Li Jun, Fan Yuechao.
Analysis of risk factors and prediction model establishment for early postoperative recurrence in glioma patients
[J]. Journal of International Oncology, 2022, 49(2): 79-83.
|
[8] |
Jin Jiahui, Chen Cunhai, Ma Xuezhen.
Effects of radiation-associated miRNA in radiotherapy for breast cancer
[J]. Journal of International Oncology, 2022, 49(12): 735-738.
|
[9] |
Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.
Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer
[J]. Journal of International Oncology, 2022, 49(11): 681-686.
|
[10] |
Kong Chunyu, Sun Pengfei.
SLC7A11 and glioma
[J]. Journal of International Oncology, 2022, 49(10): 604-607.
|
[11] |
Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.
Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis
[J]. Journal of International Oncology, 2022, 49(1): 45-50.
|
[12] |
Hong Anlan, Cao Meng, Wang Yan, Fang Fang.
Research progress on lncRNAs as members of ceRNA network in melanoma
[J]. Journal of International Oncology, 2022, 49(1): 61-64.
|
[13] |
Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.
Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis
[J]. Journal of International Oncology, 2021, 48(7): 409-414.
|
[14] |
Wang Yang, Liu Qian, Long Hui, Wu Qingming.
Research status of fecal detection for colorectal cancer markers
[J]. Journal of International Oncology, 2021, 48(7): 441-444.
|
[15] |
Jiang Mengting, Wang Jiachun, Zong Jing.
Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells
[J]. Journal of International Oncology, 2021, 48(6): 321-327.
|